SPDR S&P Pharmaceuticals ETF Rating $43.73 -0.25 (-0.57%) As of 01/17/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy 2.73Holdings in XPH have an aggregate rating of Moderate Buy based on 369 analyst ratings issued in the past year covering 45 companies (99.9% of the portfolio).XPH Aggregate Price Target$43.73High Prediction$43.73Average Prediction$43.73Low Prediction$43.73Holdings in XPH have an aggregate price target of $43.73 and a range of $43.73 to $43.73 covering 45 companies (99.9% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy21 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 45 XPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.51%ITCIIntra-Cellular Therapies$126.200.0%3.8117 of 5 stars2.67$100.31 -20.5%154.33%RPRXRoyalty Pharma$30.75-0.6%4.7373 of 5 stars3.00$41.67 35.5%7Positive News3.86%PFEPfizer$26.30-0.7%4.991 of 5 stars2.50$32.00 21.7%16Positive News3.71%JAZZJazz Pharmaceuticals$121.18-1.2%4.9805 of 5 stars2.87$177.00 46.1%15Short Interest ↓News Coverage3.68%MRKMerck & Co., Inc.$98.00-2.7%4.9993 of 5 stars2.67$123.67 26.2%21News CoveragePositive NewsHigh Trading Volume3.64%LLYEli Lilly and Company$726.24-4.1%4.9979 of 5 stars2.81$1,002.22 38.0%213.63%OGNOrganon & Co.$15.77-2.6%4.7928 of 5 stars2.40$21.33 35.3%5Positive News3.58%JNJJohnson & Johnson$147.03-0.5%4.9422 of 5 stars2.46$174.29 18.5%13Upcoming Earnings3.55%BMYBristol-Myers Squibb$56.350.0%4.9062 of 5 stars2.29$56.27 -0.2%21Positive News3.41%ZTSZoetis$166.01-2.0%4.861 of 5 stars3.09$211.89 27.6%11Positive NewsHigh Trading Volume3.40%ELANElanco Animal Health$12.03+0.1%4.3831 of 5 stars2.25$16.43 36.6%83.37%VTRSViatris$11.30-0.4%2.0264 of 5 stars2.00$13.67 20.9%33.32%AXSMAxsome Therapeutics$91.93-1.9%4.6796 of 5 stars3.00$130.69 42.2%13Analyst Revision3.28%TARSTarsus Pharmaceuticals$46.52-0.9%1.8232 of 5 stars3.00$54.20 16.5%63.24%PRGOPerrigo$23.86+0.0%4.9513 of 5 stars2.40$35.00 46.7%53.09%CORTCorcept Therapeutics$55.31+1.6%4.5373 of 5 stars3.00$65.25 18.0%5Positive News3.09%EWTXEdgewise Therapeutics$26.26-1.7%2.138 of 5 stars3.00$43.17 64.4%6Short Interest ↑Positive NewsGap Down3.03%HRMYHarmony Biosciences$39.05+1.3%4.5872 of 5 stars3.00$55.00 40.8%8Analyst Revision2.87%HROWHarrow$33.85+1.2%2.4854 of 5 stars3.00$63.00 86.1%3Positive News2.45%PBHPrestige Consumer Healthcare$78.58+0.4%3.5247 of 5 stars2.50$85.25 8.5%42.39%COLLCollegium Pharmaceutical$33.35-0.3%4.2983 of 5 stars2.80$43.80 31.3%52.03%AMPHAmphastar Pharmaceuticals$35.70+0.1%4.505 of 5 stars2.50$60.33 69.0%4Short Interest ↑2.00%ANIPANI Pharmaceuticals$58.46+1.7%4.4763 of 5 stars3.00$77.71 32.9%8Short Interest ↓Gap Down1.75%ARVNArvinas$18.05+2.7%2.532 of 5 stars2.93$63.50 251.8%151.75%PCRXPacira BioSciences$22.36+1.4%2.6459 of 5 stars2.20$24.50 9.6%101.69%CRMDCorMedix$12.17-4.8%2.4406 of 5 stars3.00$15.67 28.7%61.61%SUPNSupernus Pharmaceuticals$37.74-0.3%3.7356 of 5 stars2.67$46.50 23.2%31.44%WVEWave Life Sciences$10.99-2.8%4.4252 of 5 stars3.00$22.22 102.2%91.43%LQDALiquidia$12.89+3.0%2.9162 of 5 stars3.11$25.38 96.9%91.37%LGNDLigand Pharmaceuticals$111.89+0.7%4.959 of 5 stars3.00$147.00 31.4%61.27%OCULOcular Therapeutix$8.01-0.5%3.6599 of 5 stars2.86$16.71 108.7%7Gap Down1.26%INVAInnoviva$18.58+0.7%1.6648 of 5 stars3.001Positive News1.24%AMRXAmneal Pharmaceuticals$8.26-0.6%3.5127 of 5 stars2.80$10.00 21.1%5Short Interest ↓1.05%EOLSEvolus$10.51-0.9%4.0075 of 5 stars3.00$23.00 118.8%4News CoveragePositive News0.87%ESPREsperion Therapeutics$2.21-2.2%3.4158 of 5 stars2.40$7.30 230.3%5Gap Down0.87%EYPTEyePoint Pharmaceuticals$7.48+2.9%1.7594 of 5 stars3.00$26.63 255.9%10Short Interest ↑Gap Down0.81%ELVNEnliven Therapeutics$21.47-2.4%2.2996 of 5 stars3.20$38.25 78.2%50.80%ZVRAZevra Therapeutics$8.05+1.5%2.0132 of 5 stars3.13$21.57 168.0%80.75%PHATPhathom Pharmaceuticals$6.962.4458 of 5 stars2.75$23.00 230.5%40.67%NUVBNuvation Bio$2.51-1.4%2.2502 of 5 stars3.00$7.40 195.4%5Gap Down0.63%PLRXPliant Therapeutics$11.21-3.4%3.767 of 5 stars3.13$40.50 261.3%80.62%MNMDMind Medicine (MindMed)$7.16+10.0%2.1226 of 5 stars3.25$26.75 273.6%12High Trading Volume0.60%XERSXeris Biopharma$3.20-0.6%3.3933 of 5 stars2.67$4.87 52.1%30.53%PAHCPhibro Animal Health$20.82-0.5%4.2357 of 5 stars1.50$20.50 -1.5%40.43%NMRANeumora Therapeutics$2.05-5.5%3.6249 of 5 stars2.71$16.50 704.9%7 This page (NYSEARCA:XPH) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
